SOURCE: TheSUBWAY.com

February 14, 2008 08:23 ET

Equity Spotlight for Thursday, February 14, 2008: AERP Ongoing Expansion!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc.

WESTON, FL--(Marketwire - February 14, 2008) - TheSUBWAY.com names the following stocks to its Stock Alert List: Aero Performance Products, Inc. (PINKSHEETS: AERP), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Dendreon Corporation (NASDAQ: DNDN), ANADIGICS Inc. (NASDAQ: ANAD).

Visit TheSUBWAY's Small Cap Investor Forum Here: http://www.thesubway.com/small-cap-forum/ to discuss our daily stock picks throughout the trading day!

Aero Performance Products, Inc. (PINKSHEETS: AERP), a world leader in performance exhaust airflow technology and NASCAR Performance Partner, just announced it has struck a financing relationship with an investment banking firm to provide capital for Aero's ongoing expansion program. Aero just released its February 2008 newsletter, which includes a review of expanded domestic and international distribution, and Aero's build-out of in-house manufacturing for fabrication of its full exhaust systems. A PDF version of the newsletter is posted in the media archive of the company's website at http://www.aeroperformanceproducts.com.

In addition to the build-out, Aero is continuing to cut costs by consolidating operations into a new facility that will house the new manufacturing facility, as well as warehousing, administration, product development and marketing.

Aero recently announced new distributors around the world, including South America, Japan, Europe, the U.S., even Alaska. The Company has received preliminary patent approval for its product technology in 18 European countries. This microcap Company is growing globally!

Aero has come off of a near term high of over $.03, but is just now starting an intense public awareness campaign and attracting capital from the investment banking community. We have not seen a stock with such great prospects combined with such a low price in a very long time!

Other stocks highlighted include Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX): Stock Pick List, up 11% on 10 million shares, Dendreon Corporation (NASDAQ: DNDN): Stock Pick List, down 3% on 9 million shares, ANADIGICS Inc. (NASDAQ: ANAD): Stock Pick List, down 14% on 8 million shares.

TheSUBWAY.com's Daily Stock Updates:

TheSUBWAY.com, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to http://www.thesubway.com.

All material herein was prepared by CRG Partners, Inc. (CRGP) based upon information believed to be reliable. The information contained herein is not guaranteed by CRGP to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRGP is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.thesubway.com or mentioned herein. CRGP has been compensated by third party shareholders with shares or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRGP has been compensated twenty two million five hundred thousand shares for AERP. CRGP intends to sell its shares. CRGP and its web site are operated under a license from Capital Research Group, Inc., TheSUBWAY.com Inc. and One Source Solutions Inc. (Licensors) and CRGP is not the agent of any of the Licensors and CRGP is solely responsible for all statements made herein. CRGP's affiliates, officers, directors and employees intend to buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. CRGP will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Contact Information